At the first annual PSMA Conference, Dr. Nicholas Nickols from the University of California, Los Angeles talks about new research into PSMA that was presented and looks back at how the field has grown. He also offers insight into new Lu177 research.
Dr. Nickols on Updates in PSMA Research and Lu177
By Nicholas G. Nickols, MD, PhD - Last Updated: January 24, 2024Related Posts
Dr. Emmett discusses the Co-PSMA trial, comparing ⁶⁴Cu-SAR-bisPSMA and ⁶⁸Ga-PSMA-11 for detecting prostate cancer ...
Germline genetic testing is underused for patients with prostate cancer, despite many being eligible for the procedure.
Patients with metastatic PCa are recommended to undergo both germline and somatic DNA sequencing using panel-based assays.
Expert panel discusses diagnostic criteria, precision medicine, and PSMA imaging in managing metastatic prostate cancer.
The FDA's Fast Track Designation enables expedited development of 64Cu-SAR-bisPSMA for recurrent prostate cancer imaging.
630 Madison Ave.
Manalapan, NJ 07726
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.